U.S. federal trademark · Serial No. 79434420 · Reg. No. 8387096
Medical analysis services relating to the treatment of persons; medical analysis services for the prediction of response to cancer treatment; medical analysis services for clinical outcomes associated with cancer treatment; medical analysis services for identification of new drug targets for cancer treatment; medical analysis services for the prediction of response to cancer treatment based on computational analysis of patient's proteins; medical analysis services relating to the treatment of persons for discovering new drug targets for overcoming cancer drug resistance, based on computational analysis of patient's proteins; medical analysis services to support decision making regarding the treatment of cancer patients; medical analysis services to support treatment decisions in cancer patients; medical analysis services for the prediction of patients' response to cancer treatment and the identification of associated biological mechanisms
Source: USPTO federal trademark records. Informational only, not legal advice. Status and details may lag the live USPTO database.